title: Drug treatment of acute ischemic stroke.
abstract: Acute ischemic stroke (AIS) is the fourth leading cause of death and the leading cause of adult disability in the USA. AIS most commonly occurs when a blood vessel is obstructed leading to irreversible brain injury and subsequent focal neurologic deficits. Drug treatment of AIS involves intravenous thrombolysis with alteplase (recombinant tissue plasminogen activator [rtPA]). Intravenous alteplase promotes thrombolysis by hydrolyzing plasminogen to form the proteolytic enzyme plasmin. Plasmin targets the blood clot with limited systemic thrombolytic effects. Alteplase must be administered within a short time window to appropriate patients to optimize its therapeutic efficacy. Recent trials have shown this time window may be extended from 3 to 4.5 hours in select patients. Other acute supportive interventions for AIS include maintaining normoglycemia, euthermia and treating severe hypertension. Urgent anticoagulation for AIS has generally not shown benefits that exceed the hemorrhage risks in the acute setting. Urgent antiplatelet use for AIS has limited benefits and should only promptly be initiated if alteplase was not administered, or after 24 hours if alteplase was administered. The majority of AIS patients do not receive thrombolytic therapy due to late arrival to emergency departments and currently there is a paucity of acute interventions for them. Ongoing clinical trials may lead to further medical breakthroughs to limit the damage inflicted by this devastating disease.
authors: Department of Neurology, University of Cincinnati, College of Medicine, Cincinnati, OH 45267, USA.
authors: Sameer
authors: S
authors: Bansal
authors: Kiranpal S
authors: KS
authors: Sangha
authors: Pooja
authors: P
authors: Khatri
mesh_terms: D000818:Animals; D000959:Antihypertensive Agents / Q000008:administration & dosage; D002545:Brain Ischemia / Q000175:diagnosis / Q000188:drug therapy* / Q000453:epidemiology; D002986:Clinical Trials as Topic / Q000379:methods; D005343:Fibrinolytic Agents / Q000008:administration & dosage; D006801:Humans; D020521:Stroke / Q000175:diagnosis / Q000188:drug therapy* / Q000453:epidemiology; D015912:Thrombolytic Therapy / Q000379:methods*; D010959:Tissue Plasminogen Activator / Q000008:administration & dosage; D016896:Treatment Outcome
chemical_list: D000959:Antihypertensive Agents; D005343:Fibrinolytic Agents; D010959:Tissue Plasminogen Activator
references: Arch Neurol. 1984 Jan;41(1):26-9
references: 6606414
references: Stroke. 2001 Oct;32(10):2333-7
references: 11588322
references: N Engl J Med. 2009 Sep 10;361(11):1045-57
references: 19717846
references: N Engl J Med. 2012 Mar 22;366(12):1099-107
references: 22435369
references: N Engl J Med. 1995 Dec 14;333(24):1581-7
references: 7477192
references: Free Radic Biol Med. 2005 Jul 1;39(1):51-70
references: 15925278
references: Lancet. 2010 May 15;375(9727):1695-703
references: 20472172
references: Stroke. 2005 Nov;36(11):2415-20
references: 16224085
references: Neurology. 2004 Dec 14;63(11):2142-5
references: 15596765
references: Lancet. 1995 Dec 9;346(8989):1509-14
references: 7491044
references: Neurology. 2005 Jan 25;64(2):386-8
references: 15668451
references: J Neurol Sci. 1996 Nov;143(1-2):1-13
references: 8981292
references: Stroke. 1990 Jun;21(6):874-81
references: 2349590
references: Stroke. 2002 Jul;33(7):1821-6
references: 12105360
references: Circulation. 2011 Oct 4;124(14):1573-9
references: 21900088
references: Lancet. 1993 Nov 20;342(8882):1255-62
references: 7901582
references: Drugs. 1997;54 Suppl 3:60-9; discussion 69-70
references: 9360853
references: Lancet. 2008 Oct 11;372(9646):1303-9
references: 18790527
references: Stroke. 2011 Sep;42(9):2388-92
references: 21852609
references: Mayo Clin Proc. 1998 Sep;73(9):829-36
references: 9737218
references: Epilepsia. 2008 Jun;49(6):974-81
references: 18248443
references: CMAJ. 2000 May 2;162(9):1281-4
references: 10813008
references: Mayo Clin Proc. 2003 Feb;78(2):156-60
references: 12583526
references: Lancet. 1996 Nov 16;348(9038):1329-39
references: 8918275
references: Curr Cardiol Rep. 2004 Mar;6(2):117-23
references: 14759356
references: AJNR Am J Neuroradiol. 2004 Oct;25(9):1470-5
references: 15502123
references: J Stroke Cerebrovasc Dis. 1997 Jul-Aug;6(5):341-53
references: 17895032
references: Stroke. 2007 Jul;38(7):2127-35
references: 17525387
references: Stroke. 1999 Oct;30(10):2008-12
references: 10512899
references: Lancet Neurol. 2009 Feb;8(2):141-50
references: 19097942
references: Stroke. 2010 Apr;41(4):707-11
references: 20185783
references: Stroke. 1994 Sep;25(9):1755-9
references: 8073455
references: JAMA. 1999 Dec 1;282(21):2019-26
references: 10591384
references: N Engl J Med. 1996 Jul 18;335(3):145-50
references: 8657211
references: Lancet. 1997 Jun 7;349(9066):1641-9
references: 9186381
references: Crit Care Med. 2003 Jan;31(1):272-7
references: 12545028
references: Neurology. 1999 Jul 13;53(1):122-5
references: 10408547
references: Arch Neurol. 1996 Apr;53(4):309-15
references: 8929152
references: Lancet. 1997 May 31;349(9065):1569-81
references: 9174558
references: Neurology. 1995 Jul;45(7):1286-90
references: 7617183
references: Neurology. 1999 Jan 15;52(2):280-4
references: 9932944
references: Lancet. 1996 Sep 7;348(9028):633-8
references: 8782752
references: Int J Stroke. 2008 May;3(2):130-7
references: 18706007
references: N Engl J Med. 2011 Sep 15;365(11):981-92
references: 21870978
references: Am Heart J. 2005 Sep;150(3):401
references: 16169314
references: Neurol Clin. 2000 May;18(2):495-510
references: 10757838
references: N Engl J Med. 2007 Nov 15;357(20):2001-15
references: 17982182
references: JAMA. 1998 Apr 22-29;279(16):1265-72
references: 9565006
references: Stroke. 1997 Nov;28(11):2119-25
references: 9368551
references: Stroke. 1998 Jan;29(1):4-11
references: 9445320
references: Acta Neurol Scand. 1985 Jun;71(6):464-71
references: 4024857
references: Stroke. 2011 Jan;42(1):227-76
references: 20966421
references: Neurology. 1995 Apr;45(4):640-4
references: 7723948
references: Lancet. 2006 May 20;367(9523):1665-73
references: 16714187
references: Neurology. 2008 Mar 25;70(13):1023-9
references: 18272864
references: Cerebrovasc Dis. 2007;24(1):1-10
references: 17519538
references: AJNR Am J Neuroradiol. 2008 Aug;29(7):1409-13
references: 18499798
references: J Neurosurg. 1978 Feb;48(2):169-72
references: 624964
references: Int J Stroke. 2011 Feb;6(1):79-86
references: 21205246
references: Stroke. 2004 Feb;35(2):e27-9
references: 14739423
references: Lancet Neurol. 2007 Mar;6(3):215-22
references: 17303527
references: Lancet. 1995 Jul 1;346(8966):56
references: 7646726
references: Neurology. 1995 May;45(5):865-71
references: 7746398
references: Crit Care Med. 2003 Feb;31(2):617-25
references: 12576974
references: Lancet. 1995 Jan 7;345(8941):57
references: 7799716
references: Clin Pharmacokinet. 2008;47(5):285-95
references: 18399711
references: Stroke. 2005 Mar;36(3):583-7
references: 15662039
references: Neurology. 1998 Feb;50(2):341-50
references: 9484351
references: JAMA. 1996 Oct 23-30;276(16):1328-31
references: 8861992
references: JAMA. 2000 May 10;283(18):2395-403
references: 10815082
references: Stroke. 2007 May;38(5):1655-711
references: 17431204
references: N Engl J Med. 2011 Sep 8;365(10):883-91
references: 21830957
references: Lancet. 2004 Jul 24-30;364(9431):331-7
references: 15276392
references: Stroke. 2001 Jan;32(1):22-9
references: 11136909
references: Cerebrovasc Dis. 2005;19(6):402-4
references: 15925874
references: Stroke. 1997 May;28(5):957-60
references: 9158632
references: Circulation. 2011 Feb 1;123(4):e18-e209
references: 21160056
references: Stroke. 2008 Dec;39(12):3268-76
references: 18772447
references: N Engl J Med. 1995 Dec 14;333(24):1588-93
references: 7477193
references: Stroke. 2004 Apr;35(4):904-11
references: 15017018
references: Stroke. 1999 May;30(5):1142-3
references: 10229756
references: N Engl J Med. 2009 Sep 17;361(12):1139-51
references: 19717844
references: Stroke. 1999 Dec;30(12):2598-605
references: 10582984
references: N Engl J Med. 2008 Sep 25;359(13):1317-29
references: 18815396
references: N Engl J Med. 2008 Sep 18;359(12):1238-51
references: 18753638
references: J Intern Med. 2000 Oct;248(4):287-91
references: 11086638